Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: Cell Cycle. 2009 Mar 26;8(6):931–939. doi: 10.4161/cc.8.6.7941

Figure 5.

Figure 5

hTIN2L localizes to telomeres. (A) Immunolocalization of TIN2S-V5 expressed in 184A1 HMECs using antibodies against the hTIN2 N-terminal domain (TIN2; green) and the V5 epitope (V5; red). Arrows identify the telomere-independent nuclear domains,33 which co-stain (Merge; yellow). DAPI staining (blue) identifies nuclei. (B) Immunolocalization of TIN2L-HA expressed in 184A1 HMECs using antibodies against the hTIN2 N-terminal domain (green) and the HA epitope (red). Arrows identify telomere-independent nuclear domains,33 and DAPI staining identifies nuclei (blue). (C) Co-localization (Merge; yellow) of TIN2L-HA (HA; red) with TRF2 (TRF2; green) in nuclei (DAPI; blue).